Budesonide Spray, Metered
Product Images NDC 60505-6129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 60505-6129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Bottle Label)

Bottle-label (Bottle Label)
Budesonide Nasal Spray is a medication manufactured by Apotex Corp. with NDC 60505-6129-2 indicated for the relief of nasal allergy symptoms. It comes in a 0.2851 oz (8.43 mL) bottle and contains 32 mcg of glucocorticoid per spray, with 120 metered sprays in total. The package contains important information and should be kept along with the insert. The manufacturing of the medication takes place in Toronto, Ontario, Canada.*
FDA Label Image

Carton-label (Carton Label)

Carton-label (Carton Label)
This is a product description for Budesonide Nasal Spray, which is designed to relieve nasal allergy symptoms. The package contains 120 metered sprays (8.43mL) and includes safety instructions to store the product upright. There is also an apparent warning regarding an "arorex conn".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.